New research from Christopher Stewart, John Kepler, and Charles McClure shows that thousands of large mergers and acquisitions bypass antitrust review because current regulatory thresholds ignore intangible assets like intellectual property and customer data. These unreported deals, particularly in tech and pharma sectors, show signs of being more anticompetitive - with higher premiums paid, increased market power for acquirers, and evidence of "killer acquisitions" in pharmaceuticals.
The Domain Name System (DNS), a 1985 technical invention, was transformed into critical global infrastructure by the policies of the United States government beginning in the 1990’s. While some challenges remain, the light-touch regulation promoted by both parties has proven highly successful.
Targeted at Big Tech, Germany’s new antitrust tool for dealing with large digital platforms rebalances the power between the competition watchdog and those firms.
Around...
The new normal for millions of people represents a near-total dependence on Amazon’s cloud-computing operation, Amazon Web Services (AWS), and places a substantial portion...
Twitter banned political ads from its platform but has full discretion in deciding what constitutes a "political ad." The Stigler Center tried to promote...
The FTC sued the company that monopolized the market of components for cell phones with its aggressive patent policy. However, in the technological race...
In attempting to address legitimate privacy concerns, Google could be trying to monopolize surveillance.
As Big Tech’s leviathan wraps its tentacles around online markets,...